LISTEN: Fake friends at the FDA, cancer counter-narratives, and biotech's bear turn

LISTEN: Fake friends at the FDA, cancer counter-narratives, and biotech’s bear turn

By DAMIAN GARDE AND REBECCA ROBBINS AND ADAM FEUERSTEIN

On the podcast, we discuss a move by Celgene that has some people questioning whether a hot field in immuno-oncology might be slated for disappointment.

READ MORE